PATENT CLAIM ANALYSIS

Application Number: 16408817
Application Type: Utility
Filing Date: 2019-05
Publication Date: 2019-11
Patent Classification: ["514", "326000"]

Abstract:
Disclosed herein are methods for treating glaucoma and reducing intraocular pressure. Methods for treating glaucoma include administering a cannabinoid receptor antagonist to a subject in need thereof. Methods for reducing intraocular pressure include administering a cannabinoid receptor antagonist to a subject in need thereof. Methods for treating glaucoma also include administering a negative allosteric modulator of a cannabinoid CB 1  receptor to a subject in need thereof. Methods for reducing intraocular pressure also include administering a negative allosteric modulator of a cannabinoid CB 1  receptor to a subject in need thereof.

Claim (Index 2):
The method of  claim 1 , wherein the cannabinoid receptor antagonist is a cannabinoid CB1 receptor antagonist.

Metadata:
- Claim Count in Document: 44.0
- Percentile: 100.0
- Lexical Diversity: 3.09677
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14722991', '14009294', '14517509', '13004380', '14812566']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7124314997076883
- 35 USC 102 Novelty (BERT): 0.5128064412692381
- Combined Prediction Score: 0.6924689938638432
- Mean Citation Score: 212.606252
- Max Citation Score: 249.19432
- Similarity Product: 172.04854233192444

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test